LARYNGOSCOPE, vol.118, no.4, pp.697-705, 2008 (SCI-Expanded)
Objectives: This study aimed to evaluate the ability of topically applied calcium channel blockers (diltiazem) to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.